Evaluation of a New Surgical Technique for Macular Hole Which Was Not Closed After a Previous Surgery (ILMT)
Transposition of Internal Limiting Membrane in the Treatment of Macular Holes. A Descriptive Pilot Study
Sponsor: Groupe Hospitalier de la Region de Mulhouse et Sud Alsace
Terminated
Principal investigator left the institution
Other terminated trials from Groupe Hospitalier de la Region de Mulhouse et Sud Alsace
- Chronic Obstructive Pulmonary Disease · Aug 2025
- Low Back Pain · Phase NA · Jan 2023
- Sarcopenia · Phase NA · Sep 2022
- Muscle Spasticity · Phase NA · Mar 2020
- Age-related Cognitive Decline · Oct 2019
See all terminations from Groupe Hospitalier de la Region de Mulhouse et Sud Alsace
This NA trial investigates Retinal Perforations and is currently terminated or withdrawn. Groupe Hospitalier de la Region de Mulhouse et Sud Alsace leads this study, which shows 7 recorded versions since 2016 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
7 versions recorded-
Dec 2025 — Present [monthly]
Terminated NA
Status: Completed → Terminated
-
Sep 2024 — Dec 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Jun 2018 — Jan 2021 [monthly]
Completed NA
▶ Show 2 earlier versions
-
Aug 2017 — Jun 2018 [monthly]
Completed NA
Status: Recruiting → Completed
-
Jan 2017 — Aug 2017 [monthly]
Recruiting NA
First recorded
Nov 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Groupe Hospitalier de la Region de Mulhouse et Sud Alsace
For direct contact, visit the study record on ClinicalTrials.gov .